New waves of biological drugs may vastly improve treatment for many diseases, but not without adapted delivery devices for effective subcutaneous administration. George I’ons at Owen Mumford Pharmaceutical Services establishes why there is a need for innovative drug delivery devices that accommodate higher viscosity and higher volume formulations, typical of new biologics.